APOBEC3H is a member of the apolipoprotein B mRNA‐editing enzyme catalytic polypeptide 3 families of proteins, and it induces somatic mutagenesis in cancer cells that drive tumour evolution and may manifest clinically as recurrence, metastasis and/or therapy resistance.31 This evidence concerns the gene APOBEC3H and neoplasm.